Life Science News

Midas Letter released a podcast interview with Rob Hutchison, CEO and chairman of biOasis Technologies Inc. (TSXV:BTI,OTCQX:BIOAF).

Midas Letter released a podcast interview with Rob Hutchison, CEO and chairman of biOasis Technologies Inc. (TSXV:BTI,OTCQX:BIOAF). In it, he discusses the company’s blood brain barrier technology, which “reliably delivers therapeutic compounds beyond the Blood Brain Barrier in mice so far.”

Hutchison states:

From our perspective, biOasis has over the last number of years … actually completed all of the ground-level experimental work that was necessary to advance this technology forward. It’s now been vetted by independent third parties, including industry itself — in other words, large pharma companies have evaluated the technology. So I think it provides an opportunity for immediate potential opportunities for shareholders and investors.

Click here to listen to the podcast at the Midas Letter site.

Featured

MARKETS

Markets
TSX20099.81+400.76
TSXV696.65+29.40
DOW32196.66+466.36
S&P 5004023.89+93.81
NASD11805.00+434.04
ASX7075.10+134.10

COMMODITIES

Commodities
Gold1811.09+0.82
Silver21.11+0.03
Copper4.16+0.06
Palladium1946.01+11.99
Platinum943.12+2.88
Oil110.16+4.03
Heating Oil3.76+0.03
Natural Gas7.62-0.12

DOWNLOAD FREE REPORTS

×